China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	55	128	90	167	317	799
Market Cap Growth	-78.05%	42.37%	-46.36%	-47.18%	-60.36%	-50.88%
Enterprise Value	6	197	139	237	377	822
Last Close Price	0.18	0.42	0.29	0.55	1.11	2.80

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	1.99	4.64	5.06	-	69.56	15.42
PS Ratio	0.63	1.77	0.99	2.41	7.63	2.83
PB Ratio	0.96	2.39	3.56	14.19	3.05	7.15
P/TBV Ratio	0.96	2.39	3.56	14.19	3.05	7.15
P/FCF Ratio	3.52	31.75	5.08	15.91	-	-
P/OCF Ratio	3.51	31.21	4.90	15.51	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.07	2.73	1.53	3.41	9.08	2.91
EV/EBITDA Ratio	0.35	881.40	20.41	-	31.49	13.33
EV/EBIT Ratio	0.78	-	22.62	-	31.94	13.34
EV/FCF Ratio	0.41	48.83	7.85	22.50	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.67	0.96	2.13	4.26	0.69	0.32
Debt / EBITDA Ratio	2.09	5.45	3.14	-	4.19	0.58
Debt / FCF Ratio	2.46	12.75	3.04	4.77	-	-
Net Debt / Equity Ratio	-0.85	0.81	1.23	3.97	0.68	0.23
Net Debt / EBITDA Ratio	-5.55	193.44	4.56	-1.83	5.86	0.42
Net Debt / FCF Ratio	-3.11	10.72	1.75	4.46	-4.67	-6.76
Asset Turnover	0.57	0.47	0.56	0.30	0.16	1.38
Inventory Turnover	26.16	26.55	96.81	136.97	11.68	244.23
Quick Ratio	1.52	0.88	0.87	1.09	1.52	1.41
Current Ratio	1.57	1.14	0.99	1.14	1.58	1.75
Return on Equity (ROE)	64.18%	69.97%	95.98%	-186.16%	4.23%	183.20%
Return on Assets (ROA)	3.36%	-0.18%	2.38%	-7.07%	2.76%	18.72%
Return on Invested Capital (ROIC)	97.30%	-0.57%	10.69%	-22.44%	4.17%	111.63%
Return on Capital Employed (ROCE)	9.80%	-0.50%	8.00%	-68.50%	10.00%	55.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	50.29%	21.54%	19.78%	-64.36%	1.44%	6.49%
FCF Yield	28.40%	3.15%	19.70%	6.28%	-4.74%	-0.48%
Buyback Yield / Dilution	-	-	-6.23%	-0.34%	-	-77.64%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error